drugset / Trial / NCT00974922

Vitamin D Deficiency in Patients With Hypertension

NCT00974922

Phase 4 Terminated 40 enrolled UConn Health Novartis · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effects of Vitamin D replacement and the effects of an approved medication for hypertension, aliskiren (Tekturna), in patients with high blood pressure who have low levels of vitamin D in their blood. The study will compare the effects of vitamin D or aliskiren alone and in combination on 24-hour blood pressure and biochemical parameters.

Timeline

Start
2009-08
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 300 mg Oral